Right to Try Treatments for COVID

Canada has approved the Johnson and Johnson Janssen Ad26.COV2.S COVID-19 vaccine for use in Canada but has refused to make it available to Canadian citizens. With Canadian governments allowing employers to fire employees who are unvaccinated or deny services to those who are unvaccinated, we are launching a court action to:

1) ask the court to force the government to make the Janssen AD25.COV2.S vaccine available to Canadians and
2) make early outpatient treatment available for those who develop COVID-19 symptoms.

I am in discussions with a lawyer on how best to proceed with this lawsuit and I will give an update as soon as we have a retainer agreement.

 

Background:
Part 1

 

Johnson & Johnson’s vaccine is a single dose adenovirus vaccine, unlike the two-dose vaccines from Pfizer, Moderna and AstraZeneca. Because of how it activates the immune system, it may also confer years worth of protection. With Pfizer now announcing boosters just 6 months after the double dose protocol, it is clear the Pfizer vaccine is not able to boast lasting immunity. Other options that are approved by Health Canada and available internationally must also be available in Canada.

 

Here is an excerpt from a news story that describes how it works:

 

"Johnson & Johnson’s vaccine comes out of decades of research on adenovirus-based vaccines.

 

"After the vaccine is injected into a person’s arm, the adenoviruses bump into cells and latch onto proteins on their surface. The adenovirus also provokes the immune system by switching on the cell’s alarm systems. The cell sends out warning signals to activate immune cells nearby. By raising this alarm, the Johnson & Johnson vaccine causes the immune system to react more strongly to the spike proteins.

The cell presents fragments of the spike protein on its surface. When other cells called helper T cells detect these fragments, the helper T cells can raise the alarm and help marshal other immune cells to fight the infection.

 

"Other immune cells, called B cells, may bump into the coronavirus spikes on the surface of vaccinated cells, or free-floating spike protein fragments. A few of the B cells may be able to lock onto the spike proteins. If these B cells are then activated by helper T cells, they will start to proliferate and pour out antibodies that target the spike protein.

 

"The antigen-presenting cells can also activate another type of immune cell called a killer T cell to seek out and destroy any coronavirus-infected cells that display the spike protein fragments on their surfaces.

Johnson & Johnson’s vaccine is given as a single dose, unlike the two-dose coronavirus vaccines from Pfizer, Moderna and AstraZeneca.

 

"Researchers don’t yet know how long the vaccine’s protection might last. It’s possible that the number of antibodies and killer T cells will drop in the months after vaccination. But the immune system also contains special cells called memory B cells and memory T cells that might retain information about the coronavirus for years or even decades."

Part 2

Early treatment:

 

This website is a resource for doctors that does a real-time analysis of 876 studies for COVID early treatment.

 

https://c19early.com/

 

On the website they state:

"Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC."

 

If none of the vaccines prove to be 100 per cent available and effective for all current and future variants we believe it is an obligation of the court to allow those diagnosed with COVID-19 the right to try an early outpatient treatment protocol to reduce the chance of hospitalization and death.

 

We believe the only way to assert vaccine choice and protect personal health is to launch a court action.